| Filed On | Filing |
|---|---|
| 05 Nov 2021 | Form 3: Golubieski John, See Remarks |
| 17 Mar 2020 |
Form 3: Bailey Jeffrey Allen, Director
No securities owned |
| 03 Dec 2019 |
Form 3: Singh Vanila, Director
No securities owned |
| 18 Jan 2019 |
Form 3: Coelho Mary Theresa, See Remarks
No securities owned |
| 05 Nov 2018 |
Form 3: Vollins James, See Remarks
No securities owned |
| 01 Aug 2018 |
Form 3: Smith Thomas B, Chief Medical Officer
No securities owned |
| 23 May 2018 | Form 3: Davis Todd C, Director |
| 23 May 2018 |
Form 3: Kotler Kevin, Director and 2 others
Holds 4,278,819 shares of Common Stock |
| 23 May 2018 |
Form 3: Greenleaf Peter, Director
No securities owned |
| 08 May 2018 |
Form 3: Cukier Herm, Director
No securities owned |
| 02 Jan 2018 |
Form 3: Plesha Scott M., President
Holds 130,031 shares of Common Stock |
| 08 Dec 2017 |
Form 3: Watson W. Mark, Director
Holds 1,500 shares of Common Stock |
| 06 Oct 2016 |
Form 3: Tyson Timothy, Director
Holds 1,000 shares of Common Stock |
| 08 Jan 2016 |
Form 3: Vasisht Niraj, SVP & Chief Technology Officer
Holds 67,420 shares of Common Stock |
| 25 Jul 2014 |
Form 3: Bramlage Charles, Director
No securities owned |
| 24 Jul 2014 |
Form 3: Feinberg Barry I, Director
Holds 1,000 shares of Common Stock |
| 23 Oct 2013 |
Form 3: De Paolantonio Ernest Robert, CFO and Secretary
No securities owned |
| 29 Apr 2013 |
Form 3: D'Alonzo Thomas, Director
Holds 12,030 shares of Common Stock, par value $0.001 |
| 27 Oct 2011 |
Form 3: Sears Samuel P Jr, Director
Holds 7,000 shares of Common Stock |
| 17 Sep 2010 |
Form 3: Ward Benny, Executive Vice President
No securities owned |
Loading...
